Vaccination with inactivated murine gammaherpesvirus 68 strongly limits viral replication and latency and protects type I IFN receptor knockout mice from a lethal infection. (Q40570366)

From Wikidata

Jump to navigation Jump to search

scientific article published on March 2004

Language	Label	Description	Also known as
English	Vaccination with inactivated murine gammaherpesvirus 68 strongly limits viral replication and latency and protects type I IFN receptor knockout mice from a lethal infection.	scientific article published on March 2004

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15063566%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Vaccination with inactivated murine gammaherpesvirus 68 strongly limits viral replication and latency and protects type I IFN receptor knockout mice from a lethal infection (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15063566%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

0 references

Eleonora Aricò

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15063566%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Filippo Belardelli

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15063566%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Kevin A Robertson

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15063566%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Maria Ferrantini

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15063566%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Anthony A Nash

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15063566%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

language of work or name

0 references

publication date

1 March 2004

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15063566%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15063566%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

22

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15063566%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

11-12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15063566%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1433-1440

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15063566%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

The immunology of Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.015

7 January 2021

Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.015

7 January 2021

The role of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in lymphoproliferative diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.015

7 January 2021

Vaccine strategies against Epstein-Barr virus-associated diseases: lessons from studies on cytotoxic T-cell-mediated immune regulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.015

7 January 2021

Reflections on Epstein-Barr virus: some recently resolved old uncertainties

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.015

7 January 2021

Issues related to development of Epstein-Barr virus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.015

7 January 2021

Virological and pathological features of mice infected with murine gamma-herpesvirus 68

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.015

7 January 2021

Lung epithelial cells are a major site of murine gammaherpesvirus persistence

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.015

7 January 2021

Pathogenesis of an infectious mononucleosis-like disease induced by a murine gamma-herpesvirus: role for a viral superantigen?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.015

7 January 2021

A battle for survival: immune control and immune evasion in murine gamma-herpesvirus-68 infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.015

7 January 2021

Dissecting the host response to a gamma-herpesvirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.015

7 January 2021

Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.015

7 January 2021

CD4(+) T cell-mediated control of a gamma-herpesvirus in B cell-deficient mice is mediated by IFN-gamma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.015

7 January 2021

Analysis of virus-specific CD4(+) t cells during long-term gammaherpesvirus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.015

7 January 2021

Analysis of the virus-specific and nonspecific B cell response to a persistent B-lymphotropic gammaherpesvirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.015

7 January 2021

Murine gamma-herpesvirus 68 glycoprotein 150 protects against virus-induced mononucleosis: a model system for gamma-herpesvirus vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.015

7 January 2021

Murine gammaherpesvirus M2 gene is latency-associated and its protein a target for CD8(+) T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.015

7 January 2021

A gamma-herpesvirus sneaks through a CD8(+) T cell response primed to a lytic-phase epitope

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.015

7 January 2021

Latent antigen vaccination in a model gammaherpesvirus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.015

7 January 2021

Humoral immune response and protection from viral infection in mice vaccinated with inactivated MHV-68: effects of type I interferon

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.015

7 January 2021

A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.015

7 January 2021

Functional role of type I and type II interferons in antiviral defense

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.015

7 January 2021

Murine herpesvirus 68 is genetically related to the gammaherpesviruses Epstein-Barr virus and herpesvirus saimiri

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.015

7 January 2021

Cloning and molecular characterization of the murine herpesvirus 68 genome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.015

7 January 2021

Type I interferons and IRF-1 play a critical role in the control of a gammaherpesvirus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.015

7 January 2021

Epstein-Barr virus-recent advances

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.015

7 January 2021

Effective vaccination against long-term gammaherpesvirus latency

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.015

7 January 2021

B cells regulate murine gammaherpesvirus 68 latency

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.015

7 January 2021

based on heuristic

inferred from DOI database lookup

Macrophages are the major reservoir of latent murine gammaherpesvirus 68 in peritoneal cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.015

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40570366&oldid=1498556575"